Go Pro

L2 Asset Management LLC Purchases New Position in Chemed Corporation $CHE

Chemed logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • L2 Asset Management acquired 2,911 Chemed shares in the second quarter, valued at approximately $1.36 million. Institutional investors collectively own 95.85% of the company.
  • Chemed reported quarterly EPS of $6.06, beating estimates of $5.60, while revenue rose 8.8% year over year to $673.25 million. The company provided fiscal 2026 EPS guidance of $25.00–$25.75.
  • Chemed increased its quarterly dividend from $0.60 to $0.70 per share, although recent insider activity was negative, with insiders selling 6,537 shares worth about $3.41 million over the past 90 days.
  • Five stocks to consider instead of Chemed.

L2 Asset Management LLC acquired a new stake in Chemed Corporation (NYSE:CHE - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,911 shares of the company's stock, valued at approximately $1,356,000.

Several other institutional investors have also added to or reduced their stakes in the business. Monetary Solutions Ltd purchased a new position in shares of Chemed in the fourth quarter worth $25,000. Los Angeles Capital Management LLC purchased a new stake in shares of Chemed during the fourth quarter valued at $26,000. BOK Financial Private Wealth Inc. purchased a new stake in shares of Chemed during the fourth quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Chemed in the 2nd quarter worth about $34,000. Finally, Versant Capital Management Inc increased its holdings in Chemed by 7,500.0% in the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company's stock worth $35,000 after buying an additional 75 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Price Performance

Shares of Chemed stock opened at $540.18 on Tuesday. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The stock's fifty day moving average is $501.57 and its 200 day moving average is $447.26. The stock has a market cap of $7.06 billion, a P/E ratio of 27.13, a P/E/G ratio of 2.05 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same quarter in the previous year, the company posted $4.27 earnings per share. Chemed's revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be paid a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Monday, August 17th. This is a boost from Chemed's previous quarterly dividend of $0.60. Chemed's dividend payout ratio (DPR) is currently 14.06%.

Insiders Place Their Bets

In related news, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director owned 3,533 shares of the company's stock, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Spencer S. Lee sold 1,000 shares of the business's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $541.04, for a total value of $541,040.00. Following the completion of the transaction, the executive vice president directly owned 13,912 shares in the company, valued at approximately $7,526,948.48. This represents a 6.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 6,537 shares of company stock valued at $3,406,014 in the last ninety days. Insiders own 3.33% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CHE shares. Royal Bank Of Canada lifted their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a research note on Thursday, July 30th. Weiss Ratings upgraded shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, July 17th. Zacks Research upgraded shares of Chemed from a "strong sell" rating to a "hold" rating in a report on Monday, April 27th. Bank of America reaffirmed a "neutral" rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Oppenheimer boosted their target price on shares of Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Chemed has a consensus rating of "Hold" and an average target price of $530.75.

Check Out Our Latest Stock Report on Chemed

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

See Also

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines